Long-Term Clinical Outcomes According to Previous Manifestations of Atherosclerotic Disease (from the FAST-MI 2010 Registry)

Affiliation auteurs!!!! Error affiliation !!!!
TitreLong-Term Clinical Outcomes According to Previous Manifestations of Atherosclerotic Disease (from the FAST-MI 2010 Registry)
Type de publicationJournal Article
Year of Publication2017
AuteursPuymirat E, Aissaoui N, Lemesle G, Cottin Y, Coste P, Schiele F, Ferrieres J, Simon T, Danchin N, Investigators FAST-MI
JournalAMERICAN JOURNAL OF CARDIOLOGY
Volume119
Pagination692-697
Date PublishedMAR 1
Type of ArticleArticle
ISSN0002-9149
Résumé

The prognosis of patients with acute myocardial infarction (AMI) has notably improved in the past 20 years. Using the French Registry of ST-Elevation and Non-ST-elevation Myocardial Infarction (FAST-MI) 2010 registry, we investigated whether previous manifestations of atherosclerotic disease (i.e., previous MI, or a history of any form of atherosclerotic disease) are at truly increased risk compared with those in whom AMI is the first manifestation of the disease. FAST-MI 2010 is a nationwide French registry including 3,079 patients with AMI, among whom 1,062 patients had a history of cardiovascular atherosclerotic disease and 498 patients had a history of MI. Overall, patients with a history of atherosclerotic disease (or MI) were older compared with patients without known cardiovascular disease (71 +/- 13 vs 63 +/- 14 years) and had higher cardiovascular risk profiles and co-morbidities. Using fully adjusted Cox multivariate analysis, previous manifestations of atherosclerotic disease were associated with higher 3-year mortality (hazard ratio 1.80, 95% confidence interval 1.40 to 2.31; p < 0.001) as history of previous MI alone (hazard ratio 1.32, 95% confidenee interval 1.00 to 1.73; p = 0.048). Similar results were found in patients discharged alive. In conclusion, previous cardiovascular atherosclerotic disease represents 1/3 of patients with AMI and are strongly associated with worse long-term clinical outcomes. Intensive follow-up and therapy should be encouraged in this high-risk population. (C) 2016 Elsevier Inc. All rights reserved.

DOI10.1016/j.amjcard.2016.11.032